Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Trial Shows Treatment Desensitizes Peanut Allergies

A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year. . . . → Read More: Trial Shows Treatment Desensitizes Peanut Allergies

Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease. . . . → Read More: Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

RNA Vaccine Shows Promise with Infant Viral Diseases

A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients. . . . → Read More: RNA Vaccine Shows Promise with Infant Viral Diseases

Gut Tissue From Stem Cells Simulated on Organ Chips

Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips

NIH Exec: Research Offers Opioid Crisis Solutions

The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths. . . . → Read More: NIH Exec: Research Offers Opioid Crisis Solutions

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Engineered Virus Shows Promise in Some Brain Tumors

A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success. . . . → Read More: Engineered Virus Shows Promise in Some Brain Tumors

Report – Industry Pain, Addiction Drug Efforts Flagging

A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging

Biotechs Collaborate on Immunotherapies in $1.2B Deal

Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers. . . . → Read More: Biotechs Collaborate on Immunotherapies in $1.2B Deal

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding